Product Category Endocrinology / Diabetes Care Generic Name or Biosimilar No Active Ingredient Semaglutide Prescription Status Prescription-only in the United States, Mexico, and Canada
In clinical trials, patients on tirzepatide lost an average of about 21% of body weight over 72 weeks
Obes Surg 34(4):13241332 St-Pierre J, Klein J, Choi NK et al (2024) Efficacy and safety of GLP-1 agonists on metabolic parameters in non-diabetic patients with inflammatory bowel disease
Safety, efficacy and pharmacokinetics of repeat subcutaneous dosing of avexitide (exendin 9-39) for treatment of post-bariatric hypoglycaemia
And how can you tell if weight loss medication will work for you
International journal of molecular sciences, 24(23), 16588